Key result
Exercise tolerance testing in asymptomatic adults provides independent prognostic information for future coronary heart disease events (RR 2.0 to 5.0), but its effect on clinical outcomes is unclear.
Why the study?
Does exercise tolerance testing added to traditional risk assessment improve coronary heart disease outcomes in asymptomatic adults with no history of cardiovascular disease?
Population
Adults with no history of cardiovascular disease (asymptomatic patients)
Comparison
Exercise tolerance testing added to traditional… vs Traditional risk assessment alone
Design
Systematic_review
Authors
Loading...
Adds prognostic value without proven outcome benefit in asymptomatic adults; leaves open whether routine testing improves clinical events.
Systematic Review
Does exercise tolerance testing added to traditional risk assessment improve coronary heart disease outcomes in asymptomatic adults with no history of cardiovascular disease?
Effect estimate: RR 2.0 to 5.0
Screening asymptomatic adults with exercise tolerance testing provides prognostic information but its effect on clinical outcomes remains unclear and carries a risk of false positives.
Fowler‐Brown et al. (2004) conducted a systematic review in Coronary Heart Disease. Exercise tolerance testing vs. Traditional risk assessment was evaluated on Future coronary heart disease events (RR 2.0 to 5.0). Exercise tolerance testing in asymptomatic adults provides independent prognostic information for future coronary heart disease events (RR 2.0 to 5.0), but its effect on clinical outcomes is unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: